Compare RSI & VCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RSI | VCEL |
|---|---|---|
| Founded | 2012 | 1989 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Services-Misc. Amusement & Recreation | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 2.0B |
| IPO Year | N/A | 1997 |
| Metric | RSI | VCEL |
|---|---|---|
| Price | $18.39 | $36.36 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 8 | 6 |
| Target Price | $21.14 | ★ $60.40 |
| AVG Volume (30 Days) | ★ 1.1M | 626.9K |
| Earning Date | 10-29-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 236.54 |
| EPS | ★ 0.32 | 0.25 |
| Revenue | ★ $1,063,702,000.00 | $258,716,999.00 |
| Revenue This Year | $21.74 | $17.86 |
| Revenue Next Year | $16.09 | $18.55 |
| P/E Ratio | ★ $57.76 | $149.06 |
| Revenue Growth | ★ 23.15 | 14.05 |
| 52 Week Low | $9.54 | $29.24 |
| 52 Week High | $22.65 | $63.00 |
| Indicator | RSI | VCEL |
|---|---|---|
| Relative Strength Index (RSI) | 54.14 | 43.46 |
| Support Level | $18.43 | $37.28 |
| Resistance Level | $19.19 | $42.68 |
| Average True Range (ATR) | 0.60 | 1.78 |
| MACD | 0.19 | -0.55 |
| Stochastic Oscillator | 65.86 | 6.89 |
Rush Street Interactive Inc is an online gaming and entertainment company that focuses on online casinos and online sports betting in the U.S. and Latin American markets. It provides customers with an array of gaming offerings such as real-money online casinos, online sports betting, and retail sports betting, as well as social gaming, which involves free-to-play games that use virtual credits that can be earned or purchased. The company generates revenue by offering online casinos, online sports betting, and social gaming directly to the end customer through its websites or apps. The company generates revenue through business-to-consumer (B2C) and business-to-business (B2B) models.
Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.